Integrated Diagnostics Holdings plc

LSE:IDHC Voorraadrapport

Marktkapitalisatie: US$289.2m

Integrated Diagnostics Holdings Toekomstige groei

Future criteriumcontroles 5/6

Integrated Diagnostics Holdings is forecast to grow earnings and revenue by 23.7% and 19.1% per annum respectively. EPS is expected to grow by 20.9% per annum. Return on equity is forecast to be 34.4% in 3 years.

Belangrijke informatie

23.7%

Groei van de winst

20.9%

Groei van de winst per aandeel

Healthcare winstgroei23.0%
Inkomstengroei19.1%
Toekomstig rendement op eigen vermogen34.4%
Dekking van analisten

Low

Laatst bijgewerkt22 Oct 2024

Recente toekomstige groei-updates

Recent updates

Integrated Diagnostics Holdings (LON:IDHC) Will Be Hoping To Turn Its Returns On Capital Around

Nov 07
Integrated Diagnostics Holdings (LON:IDHC) Will Be Hoping To Turn Its Returns On Capital Around

Is Integrated Diagnostics Holdings (LON:IDHC) A Risky Investment?

Oct 17
Is Integrated Diagnostics Holdings (LON:IDHC) A Risky Investment?

Returns On Capital Signal Tricky Times Ahead For Integrated Diagnostics Holdings (LON:IDHC)

Jun 22
Returns On Capital Signal Tricky Times Ahead For Integrated Diagnostics Holdings (LON:IDHC)

Integrated Diagnostics Holdings' (LON:IDHC) Problems Go Beyond Weak Profit

Nov 25
Integrated Diagnostics Holdings' (LON:IDHC) Problems Go Beyond Weak Profit

Does Integrated Diagnostics Holdings (LON:IDHC) Have A Healthy Balance Sheet?

Sep 06
Does Integrated Diagnostics Holdings (LON:IDHC) Have A Healthy Balance Sheet?

Winst- en omzetgroeiprognoses

LSE:IDHC - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EGP Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20267,7281,2871,1131,4393
12/31/20256,5039758171,1093
12/31/20245,2378721263812
6/30/20244,748817607839N/A
3/31/20244,378755265559N/A
12/31/20234,123510218544N/A
9/30/20233,858538190514N/A
6/30/20233,5233425335N/A
3/31/20233,340417-362-1N/A
12/31/20223,605541-100209N/A
9/30/20224,258716417700N/A
6/30/20224,8861,1881,1171,438N/A
3/31/20225,2761,3831,8242,091N/A
12/31/20215,2251,4132,0062,270N/A
9/30/20214,7531,3221,9232,153N/A
6/30/20214,0001,0621,4461,600N/A
3/31/20213,286816N/AN/AN/A
12/31/20202,656594757883N/A
9/30/20202,247523N/AN/AN/A
6/30/20202,115466452621N/A
3/31/20202,180491N/AN/AN/A
12/31/20192,226511479697N/A
9/30/20192,193508N/AN/AN/A
6/30/20192,117510287621N/A
3/31/20192,035518N/AN/AN/A
12/31/20181,921502225556N/A
9/30/20181,790447N/AN/AN/A
6/30/20181,695435273434N/A
3/31/20181,605405N/A418N/A
12/31/20171,514374N/A403N/A
9/30/20171,425343N/AN/AN/A
6/30/20171,303292N/A416N/A
3/31/20171,237276N/A407N/A
12/31/20161,171260N/A399N/A
9/30/20161,116247N/AN/AN/A
6/30/20161,074251N/A311N/A
3/31/20161,044198N/A250N/A
12/31/20151,015145N/A190N/A
9/30/2015980134N/AN/AN/A
6/30/201593793N/A212N/A
3/31/2015898113N/A257N/A
12/31/2014860133N/A302N/A
9/30/2014807105N/AN/AN/A
12/31/201367262N/A209N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: IDHC's forecast earnings growth (23.7% per year) is above the savings rate (1.9%).

Winst versus markt: IDHC's earnings (23.7% per year) are forecast to grow faster than the UK market (14.4% per year).

Hoge groeiwinsten: IDHC's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: IDHC's revenue (19.1% per year) is forecast to grow faster than the UK market (3.6% per year).

Hoge groei-inkomsten: IDHC's revenue (19.1% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: IDHC's Return on Equity is forecast to be high in 3 years time (34.4%)

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y